Acessibilidade / Reportar erro

Gastroplasty as a treatment for type 2 diabetes mellitus

BACKGROUND: Diabetes mellitus type 2 is not infrequently associated with obesity and can be prevented, improved and even reversed with the different types of bariatric operations. AIM: To compare serum glucose levels on pre and post-operative periods in patients undergoing gastroplasty with Capella and gastric sleeve techniques. METHOD: A descriptive and prospective analysis of serum glucose levels was done on pre and post-operative patients undergoing these operations. RESULTS: Of the 83 patients analyzed, 76 (91.5%) were female. Ages ranged from 21 to 64 years, with average age of 44 years. Seventy-seven (92.7%) underwent gastroplasty (Capella) and six (7.3%) to gastric sleeve. The pre-operative blood glucose ranged from 125 to 500 mg / dL and dropped to 76 to 120 mg / dL in the post-operative period of three months. Of the 77 patients taking medication for diabetes, 57 had metformin 850 to 3500 mg daily, 18 glibenclamide 5 to 10 mg per day and 17 insulin. After three months of operation, 92.2% stopped using drugs for diabetes and 100% of those who remained medicated decreased from more than 65% the dose of the drug, and none remained dependent of insulin treatment. CONCLUSION: Bariatric surgery is effective method to improve and even reverse type 2 diabetes mellitus.

Gastroplasty; Diabetes mellitus; morbid obesity


Colégio Brasileiro de Cirurgia Digestiva Av. Brigadeiro Luiz Antonio, 278 - 6° - Salas 10 e 11, 01318-901 São Paulo/SP Brasil, Tel.: (11) 3288-8174/3289-0741 - São Paulo - SP - Brazil
E-mail: revistaabcd@gmail.com